COMMUNIQUÉS West-GlobeNewswire

Atrion Reports First Quarter 2024 Results
10/05/2024
ALLEN, Texas, May 10, 2024 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI) today announced its results for the first quarter ended March 31, 2024. Revenues for the first quarter of 2024 totaled $47.3 million [...]
Ocugen Announces Distribution of Series C Preferred Stock to Holders of its Common Stock
10/05/2024
MALVERN, Pa., May 10, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and [...]
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10/05/2024
SAN FRANCISCO, May 10, 2024 (GLOBE NEWSWIRE) -- 89bio, Inc. (the “Company” or “89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies [...]
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10/05/2024
MALVERN, Pa., May 10, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today [...]
Longeveron Announces Board of Directors Planned Transitions
10/05/2024
Richard Kender, retired SVP of Business Development and Corporate Licensing for Merck & Co., Inc., has been appointed to the Longeveron Board Dr. Roger Hajjar, former head of R&D at Ring Therapeutics, has been [...]
Cassava Sciences Reports Q1 2024 Financial Results and Clinical Updates on Phase 3 Trials of Simufilam
10/05/2024
$126.3 Million In Total Gross Proceeds from Warrant Distribution. Over 1,900 Patients with Alzheimer’s Disease Are Randomized in Phase 3 Trials of Simufilam. Over 735 Patients Have Completed a Phase 3 Trial of Simufilam [...]
Assertio to Present at the Citizens JMP Life Sciences Conference in New York City
10/05/2024
LAKE FOREST, Ill., May 10, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated [...]
Optinose Announces Reporting Date for First Quarter 2024 Financial Results
10/05/2024
Conference Call and Webcast to be held May 14, 2024, at 10:00 a.m. Eastern Time YARDLEY, Pa., May 10, 2024 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose [...]
NeuroOne® to Report Second Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on May 14
10/05/2024
EDEN PRAIRIE, Minn., May 10, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and [...]
Le King Faisal Specialist Hospital & Research Centre chef de file de la transformation du secteur de la santé en Arabie saoudite
10/05/2024
RIYAD, Arabie saoudite, 10 mai 2024 (GLOBE NEWSWIRE) -- Université de Harvard -- Huit ans après le lancement du projet « Vision 2030 », l’Arabie saoudite a réalisé des pas de géant en termes d’innovation numérique et d’ [...]
Nika Pharmaceuticals, Inc. (NIKA) Acquires a Two Million USD Production Building
10/05/2024
HENDERSON, Nev., May 10, 2024 (GLOBE NEWSWIRE) -- Nika Pharmaceuticals, Inc. (OTCMKTS: NIKA ) announces that it is the beneficial owner of a production building and land valued at $2,045,209, located in Sofia Province, [...]
Nika Pharmaceuticals, Inc. (Nika) Acquires a Two Million USD Production Building
10/05/2024
HENDERSON, Nev., May 10, 2024 (GLOBE NEWSWIRE) -- Nika Pharmaceuticals, Inc. (OTCMKTS: NIKA ) announces that it is the beneficial owner of a production building and land valued at $2,045,209, located in Sofia Province, [...]
AFB Releases Phase 2 Study of Barriers to Digital Inclusion
10/05/2024
WASHINGTON, May 10, 2024 (GLOBE NEWSWIRE) -- The American Foundation for the Blind (AFB) released this week its latest study in a series examining the digital inclusion of people with disabilities on websites and mobile [...]
Merus annonce ses résultats financiers pour le premier trimestre 2024 et fait le point sur ses activités
10/05/2024
Données cliniques intermédiaires initiales concernant le pétosemtamab en association avec le pembrolizumab en traitement de 1 re ligne du CETC présentées lors du congrès annuel de l’ASCO 2024 ; éventuel essai de phase [...]
ACTG SLIM LIVER Findings Published in Annals of Internal Medicine
10/05/2024
LOS ANGELES, May 10, 2024 (GLOBE NEWSWIRE) -- ACTG, a global clinical trials network focused on HIV and other infectious diseases, today announced the publication of results from SLIM LIVER (also known as A5371) in the [...]
KFSH&RC Pushes Boundaries with a Year of Achievements Across Three Centres of Excellence
10/05/2024
RIYADH, Saudi Arabia, May 10, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSH&RC) has experienced a year of achievements across its three Centres of Excellence—Oncology, Genomics [...]
CannaCon West Coming to the Albuquerque Convention Center in May 2024
10/05/2024
ALBUQUERQUE, N.M., May 10, 2024 (GLOBE NEWSWIRE) -- via CannabisNewsWire (“CNW”) — CannaCon , a leading conference company that produces cutting-edge B2B events for cannabis businesses, marijuana entrepreneurs, [...]
Immix Biopharma Announces Positive NXC-201 Relapsed/Refractory AL Amyloidosis Clinical Data in ASGCT 2024 Late Breaking Oral Presentation
10/05/2024
92% (12/13) overall response rate (ORR) for relapsed/refractory AL Amyloidosis patients enrolled in NEXICART-1: 12 out of 12 patients not exposed to prior BCMA-targeted bispecific responded to NXC-201 (100% ORR), of [...]
Healthcare Integrated Technologies, Inc. Welcomes Ryan Holland to its Board of Directors
10/05/2024
Knoxville, Tennessee, May 10, 2024 (GLOBE NEWSWIRE) -- Healthcare Integrated Technologies, Inc. (“HiTC”), a pioneer in developing advanced healthcare technology solutions, is excited to announce the appointment of Ryan [...]

Pages